Retatrutide Trial Result Calculator
Convert Lilly's reported TRIUMPH-1 percentage results into simple weight-change ranges for evidence review only.
Direct answer
Enter a baseline weight and the tool shows what Lilly's reported 4 mg, 9 mg, and 12 mg average percentage changes would equal. It's not a prediction and not dosing advice.
Your target marker
20% from 100.0 kg equals about 20.0 kg, or a remaining weight of 80.0 kg.
4 mg
Lilly reported 21.4 kg / 47.2 lb on the trial baseline.
19% equals about 19.0 kg from your baseline.
Simple range marker: 17.0 kg to 21.0 kg.
80-week average translated
81.0 kg remaining
9 mg
Lilly reported 29.2 kg / 64.4 lb on the trial baseline.
25.9% equals about 25.9 kg from your baseline.
Simple range marker: 23.9 kg to 27.9 kg.
80-week average translated
74.1 kg remaining
12 mg
Lilly reported 31.9 kg / 70.3 lb on the trial baseline.
28.3% equals about 28.3 kg from your baseline.
Simple range marker: 26.3 kg to 30.3 kg.
80-week average translated
71.7 kg remaining
This converts Lilly's reported TRIUMPH-1 averages into kilograms. It is not a personal forecast, treatment plan, dosing guide, or safety assessment.
Tool output is for evidence review only. It's not medical advice, treatment advice, dosing guidance, or a personal outcome prediction.
Research peptides are not approved by the TGA for human use. Supplier links are for checking visible batch and payment details, not medical advice.
Does this calculator predict my result?+
No. It only converts Lilly's reported TRIUMPH-1 averages into kilograms for a baseline weight you enter. It cannot predict an individual result.
Which TRIUMPH-1 arms are included?+
The tool uses Lilly's reported 4 mg, 9 mg, and 12 mg efficacy-estimand figures at 80 weeks: 19.0%, 25.9%, and 28.3%.
Is this dosing advice?+
No. The calculator is an evidence-review tool only. It does not recommend a dose, treatment, or medical route.
Other tools
Useful checks beat loud claims.